Standing at the Crossroads: A Grounded Theory of Early-Stage Desistance From Heroin Careers in Malta
Journal of Drug Issues · 03.06.2026
DOI: 10.1177/00220426261456683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Issues, online erschienen am 03.06.2026. Verfasst von Manuel Gellel und 2 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Evidence suggests that individuals affected by problematic heroin use can desist at various points in their drug-using career. Drawing on a doctoral study that developed a non-linear four-stage model of desistance from heroin careers within the Maltese context, this paper focuses on exploring the contingencies that are in place during the initial pre-desistance stage. The study adopted an evolved grounded theory methodology. Semi-structured interviews were conducted with twenty-two participants, fourteen identifying as male and eight as female, who had desisted from heroin careers for a minimum of five years. Findings show that a series of setbacks encountered after committing to a heroin career can create profound ambivalence, leading to pivotal reckoning moments that prompt individuals to consider change. Importantly, the emergence of hope that desistance is possible appears to play an instrumental role in initiating the desistance process.
Zitieren
APA
Gellel, M., Clark, M., & Bell, A. (2026). Standing at the Crossroads: A Grounded Theory of Early-Stage Desistance From Heroin Careers in Malta. Journal of Drug Issues. https://doi.org/10.1177/00220426261456683
Vancouver
Gellel M, Clark M, Bell A. Standing at the Crossroads: A Grounded Theory of Early-Stage Desistance From Heroin Careers in Malta. Journal of Drug Issues. 2026. doi:10.1177/00220426261456683
BibTeX
@article{Gellel2026,
author = {Gellel, Manuel and Clark, Marilyn and Bell, Albert},
title = {Standing at the Crossroads: A Grounded Theory of Early-Stage Desistance From Heroin Careers in Malta},
journal = {Journal of Drug Issues},
year = {2026},
doi = {10.1177/00220426261456683}
}
EUVIMED